| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | MPP6 |
| Uniprot No | Q9NZW5 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-540aa |
| 氨基酸序列 | MQQVLENLTE LPSSTGAEEI DLIFLKGIME NPIVKSLAKA HERLEDSKLE AVSDNNLELV NEILEDITPL INVDENVAEL VGILKEPHFQ SLLEAHDIVA SKCYDSPPSS PEMNNSSINN QLLPVDAIRI LGIHKRAGEP LGVTFRVENN DLVIARILHG GMIDRQGLLH VGDIIKEVNG HEVGNNPKEL QELLKNISGS VTLKILPSYR DTITPQQVFV KCHFDYNPYN DNLIPCKEAG LKFSKGEILQ IVNREDPNWW QASHVKEGGS AGLIPSQFLE EKRKAFVRRD WDNSGPFCGT ISSKKKKKMM YLTTRNAEFD RHEIQIYEEV AKMPPFQRKT LVLIGAQGVG RRSLKNRFIV LNPTRFGTTV PFTSRKPRED EKDGQAYKFV SRSEMEADIK AGKYLEHGEY EGNLYGTKID SILEVVQTGR TCILDVNPQA LKVLRTSEFM PYVVFIAAPE LETLRAMHKA VVDAGITTKL LTDSDLKKTV DESARIQRAY NHYFDLIIIN DNLDKAFEKL QTAIEKLRME PQWVPISWVY |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇关于MPP6重组蛋白研究的代表性文献(内容基于真实研究概括，部分信息为示例性描述)：
---
1. **文献名称**: *Molecular characterization of recombinant MPP6 and its interaction with scaffolding proteins in neuronal synapses*
**作者**: Tanaka, K., et al.
**摘要**: 研究利用大肠杆菌系统表达并纯化重组人源MPP6蛋白，通过免疫共沉淀实验证明其与突触后支架蛋白SAP97的相互作用，揭示MPP6在神经元突触信号传导复合体组装中的潜在作用。
---
2. **文献名称**: *Crystal structure of the PDZ domain of MPP6 reveals its specific binding motif*
**作者**: Zhang, Y., et al.
**摘要**: 报道了MPP6的PDZ结构域重组蛋白的X射线晶体结构(分辨率2.1Å)，通过体外结合实验鉴定其特异性识别C端疏水性氨基酸序列的分子机制，为设计靶向该结构域的抑制剂奠定基础。
---
3. **文献名称**: *MPP6 knockout mice exhibit impaired learning and memory via disrupted AMPA receptor trafficking*
**作者**: Lee, S., et al.
**摘要**: 通过构建MPP6基因敲除小鼠模型，结合重组MPP6蛋白的体外功能回补实验，证明MPP6通过调控AMPA受体亚基GluA1的膜转运参与海马依赖性学习记忆过程。
---
4. **文献名称**: *Reconstitution of the Scribble-MPP6 complex and its role in cell polarity regulation*
**作者**: Navarro, C., et al.
**摘要**: 在昆虫细胞中重组表达MPP6与Scribble蛋白的复合体，通过体外Pull-down和活细胞成像技术揭示二者通过L27结构域介导的相互作用对上皮细胞极性建立的调控机制。
---
注：以上文献信息为基于领域知识的概括性模拟，具体研究请以实际文献为准。如需真实文献，建议在PubMed或Web of Science中以“MPP6 recombinant”或“MPP6 protein interaction”为关键词检索。
MPP6 (MAGUK p55 subfamily member 6), also known as PALS2. is a member of the membrane-associated guanylate kinase (MAGUK) protein family. These proteins are characterized by their modular domains, typically including PDZ, SH3. and GuK (guanylate kinase-like) domains, which enable scaffolding functions in cellular signaling and structural organization. MPP6 is primarily recognized for its role in maintaining cell polarity and regulating synaptic protein networks, particularly in neurons and epithelial cells. It interacts with other MAGUK proteins like PALS1 and STAU1. contributing to the formation of multiprotein complexes that stabilize cell junctions and coordinate intracellular trafficking.
Recombinant MPP6 proteins are engineered using expression systems (e.g., E. coli, mammalian cells) to study its biochemical properties, interactions, and functional mechanisms. These purified proteins retain key domains critical for binding partners, enabling in vitro assays such as pull-down experiments, crystallography, or fluorescence-based interaction studies. Research has linked MPP6 to neurological processes, including neurite outgrowth and synaptic plasticity, as well as diseases like cancer and neurodevelopmental disorders. Dysregulation of MPP6 has been observed in glioblastoma and colorectal cancer, suggesting its potential as a therapeutic target.
The development of recombinant MPP6 has advanced structural studies, revealing how its PDZ domain recognizes specific C-terminal motifs of partner proteins, while the GuK domain mediates dimerization. Such insights help decipher its role in cellular homeostasis and disease pathways. Additionally, recombinant MPP6 serves as a tool for drug screening, antibody production, and CRISPR-based functional genomics. Despite progress, questions remain about its tissue-specific isoforms and post-translational modifications, driving ongoing research to fully elucidate its biological and pathological significance.
在生物科技领域，蛋白研发与生产是前沿探索的关键支撑。艾普蒂作为行业内的创新者，凭借自身卓越的研发实力，每年能成功研发 1000 多种全新蛋白，在重组蛋白领域不断突破。 在重组蛋白生产过程中，艾普蒂积累了丰富且成熟的经验。从结构复杂的跨膜蛋白，到具有特定催化功能的酶、参与信号传导的激酶，再到用于免疫研究的病毒抗原，艾普蒂都能实现高效且稳定的生产。 这一成就离不开艾普蒂强大的技术平台。我们构建了多元化的重组蛋白表达系统，昆虫细胞、哺乳动物细胞以及原核蛋白表达系统协同运作。不同的表达系统各有优势，能够满足不同客户对重组蛋白的活性、产量、成本等多样化的需求，从而提供高品质、低成本的活性重组蛋白。 艾普蒂提供的不只是产品，更是从源头到终端的一站式解决方案。从最初的基因合成，精准地构建出符合要求的基因序列，到载体构建，为蛋白表达创造适宜的环境，再到蛋白质表达和纯化，每一个环节都严格把控。我们充分尊重客户的个性化需求，在表达 / 纯化标签的选择、表达宿主的确定等方面，为客户量身定制专属方案。 同时，艾普蒂还配备了多种纯化体系，能够应对不同特性蛋白的纯化需求。这种灵活性和专业性，极大地提高了蛋白表达和纯化的成功率，让客户的研究项目得以顺利推进，在生物科技的探索道路上助力每一位科研工作者迈向成功。
艾普蒂生物自主研发并建立综合性重组蛋白生产和抗体开发技术平台，包括： 哺乳动物细胞表达平台：利用哺乳动物细胞精准修饰蛋白，产出与天然蛋白相似的重组蛋白，用于药物研发、细胞治疗等。 杂交瘤开发平台：通过细胞融合筛选出稳定分泌单克隆抗体的杂交瘤细胞株，优化后的技术让抗体亲和力与特异性更高，应用于疾病诊断、免疫治疗等领域。 单 B 细胞筛选平台：FACS 用荧光标记和流式细胞仪快速分选特定 B 细胞；Beacon® 基于微流控技术，单细胞水平捕获、分析 B 细胞，挖掘抗体多样性，缩短开发周期。 凭借这些平台，艾普蒂生物为客户提供优质试剂和专业 CRO 技术服务，推动生物科技发展。
艾普蒂生物在重组蛋白和天然蛋白开发领域经验十分丰富，拥有超过 2 万种重组蛋白的开发案例。在四大重组蛋白表达平台的运用上，艾普蒂生物不仅经验老到，还积累了详实的成功案例。针对客户的工业化生产需求，我们能够定制并优化实验方案。通过小试探索、工艺放大以及条件优化等环节，对重组蛋白基因序列进行优化，全面探索多种条件，精准找出最契合客户需求的生产方法。 此外，公司还配备了自有下游验证平台，可对重组蛋白展开系统的质量检测与性能测试，涵盖蛋白互作检测、活性验证、内毒素验证等，全方位保障产品质量。 卡梅德生物同样重视蛋白工艺开发，确保生产出的蛋白质具备所需的纯度、稳定性与生物活性，这对于保障药物的安全性和有效性起着关键作用 ，与艾普蒂生物共同推动着行业的发展。
×
